Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines

Genes Chromosomes and Cancer

Volumn 45, Issue 3, 2006, Pages 277-289

  French, Juliet D ^a   Dunn, Jasmyn ^a   Smart, Chanel E ^a   Manning, Nathan ^b   Brown, Melissa A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ANAPHASE; ARTICLE; CELL FUNCTION; CELL IMMORTALIZATION; CELL LINE; ENZYME ACTIVITY; EPITHELIUM CELL; GENE DISRUPTION; GENE MUTATION; GENETIC STABILITY; HUMAN; HUMAN CELL; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TELOMERE; TUMOR SUPPRESSOR GENE;

ANAPHASE; CELL LINE, TRANSFORMED; GENES, BRCA1; HUMANS; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; TELOMERASE; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 32544442886     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20290     Document Type: Article

References (40)

1. Al-Wahiby S, Slijepcevic P. 2005. Chromosomal aberrations involving teiomeres in BRCA1 deficient human and mouse cell lines. Cytogenet Genome Res 109:491-496.
2. Bailey SM, Meyne J, Chen DJ, Kurimasa A, Li GC, Lehnert BE, Goodwin EH. 1999. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci USA 96:14899-14904.
3. Baumann P, Podell E, Cech TR. 2002. Human Pot1 (protection of telomeres) protein: cytolocalixation, gene structure, and alternative splicing. Mol Cell Biol 22:8079-8087.
4. Begovich A, Francke U. 1979. Karyotype evolution of the simian virus 40-transformed human cell line LNSV. Cytogenet Cell Genet 23:3-11.
5. Bradshaw PS, Stavropoulos DJ, Meyn MS. 2005. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat Genet 37:193-197.
6. Brown MA, Nicolai H, Howe K, Katagiri T, Lalani el N, Simpson KJ, Manning NW, Deans A, Chen P, Khanna KK, Wati MR, Griffiths BL, Xu CF, Stamp GW, Solomon E. 2002. Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice. Transgenic Res 11:467-478.
7. Cabuy E, Newton C, Joksic G, Woodbine L, Koller B, Jeggo PA, Slijepcevic P. 2005. Accelerated telomere shortening and telomere abnormalities in radiosensitive cell lines. Radiation Research 164:53-62.
8. de Lange T. 2002. Protection of mammalian telomeres. Oncogene 21:532-540.
9. Deng CX. 2002. Roles of BRCA1 in centrosome duplication. Oncogene 21:6222-6227.
10. Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, Sabatier L. 2003. Telomere-driven genomic instability in cancer cells. Cancer Lett 194:173-182.
11. Double JA. 2002. Telomerase as a therapeutic target. Therapeutic potential of telomerase inhibitors. Methods Mol Biol 191:209-216.
12. Fan S, Yuan R, Ma YX, Meng Q, Goldberg ID, Rosen EM. 2001. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 20:8215-8235.
13. Gisselsson D. 2003. Chromosome instability in cancer: how, when, and why? Adv Cancer Res 87:1-29.
14. Grigorova M, Staines JM, Ozdag H, Caldas C, Edwards PA. 2004. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1. Cytogenet Genome Res 104:333-340.
15. Hande P, Slijepcevic P, Silver A, Bouffler S, van Buul P, Bryant P, Lansdorp P. 1999. Elongated telomeres in scid mice. Genomics 56:221-223.
16. Johannsson OT, Staff S, Vallon-Christersson J, Kytola S, Gudjonsson T, Rennstam K, Hedenfalk IA, Adeyinka A, Kjellen E, Wennerberg J, Baldetorp B. Petersen OW, Olsson H, Oredsson S, Isola J, Borg A. 2003. Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab Invest 83:387-396.
17. Karlseder J, Smogorzewska A, de Lange T. 2002. Senescence induced by altered telomere state, not telomere loss. Science 295:2446-2449.
18. Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, Nakayama H, Yasui W. 2004. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64:523-529.
19. Liu D, O'connor MS, Qin J, Songyang Z. 2004a. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279:51338-51342.
20. Liu D, Safari A, O'connor MS, Chan DW, Laegeler A, Qin J, Songyang Z. 2004b. PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol 6:673-680.
21. Mathieu N, Pirzio L, Freulet-Marriere MA, Desmaze C, Sabatier L. 2004. Telomeres and chromosomal instability. Cell Mol Life Sci 61:641-656.
22. Mattern KA, Swiggers SJ, Nigg AL, Lowenberg B, Houtsmuller AB, Zijlmans JM. 2004. Dynamics of protein binding to telomeres in living cells: implications for telomere structure and function. Mol Cell Biol 24:5587-5594.
23. McPherson JP, Lemmers B, Hirao A, Hakem A, Abraham J, Migon E, Matysiak-Zablocki E, Tamblyn L, Sanchez-Sweatman O, Khokha R, Squire J, Hande MP, Mak TW, Hakem R. 2004. Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev 18:1144-1153.
24. Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Marzo AM, Argani P. 2004. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol 164:925-935.
25. Moran-Jones K, Wayman L, Kennedy DD, Reddel RR, Sara S, Snee MJ, Smith R. 2005. hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res 33:486-496.
26. Murnane JP, Sabatier L. 2004. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26:1164-1174.
27. Reddel RR. 2003. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 194:155-162.
28. Rosen EM, Fan S, Pestell RG, Goldberg ID. 2003. BRCA1 gene in breast cancer. J Cell Physiol 196:19-41.
29. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. 1998. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 16:743-747.
30. Samper E, Goytisolo FA, Slijepcevic P, van Buul PP, Blasco MA. 2000. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep 1:244-252.
31. Simpson KJ, Wati MR, Deans AJ, Lindeman GJ, Brown MA. 2004. MMTV-trBrca1 mice display strain-dependent abnormalities in vaginal development. Int J Dev Biol 48:675-678.
32. Smogorzewska A, Karlseder J, Holtgreve-Grez H, Jauch A, de Lange T. 2002. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol 12:1635-1644.
33. Stavropoulos DJ, Bradshaw PS, Li X, Pasic I, Truong K, Ikura M, Ungrin M, Meyn MS. 2002. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet 11:3135-3144.
34. van Steensel B, Smogorzewska A, de Lange T. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413.
35. Watters D, et al. 1997. Cellular localisation of the ataxia- telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14:1911-1921.
36. Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX, Ried T. 2002. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene 21:5097-5107.
37. Wege H, Chui MS, Le HT, Tran JM, Zern MA. 2003. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31:E3-3.
38. Wu G, Jiang X, Lee WH, Chen PL. 2003. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res 63:2589-2595.
39. Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM. 2003. BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 23:8668-8690.
40. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175-4179.